Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, April 9, 2019
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
Mon, April 8, 2019
[ Mon, Apr 08th 2019
] - WOPRAI
[ Mon, Apr 08th 2019
] - WOPRAI
[ Mon, Apr 08th 2019
] - WOPRAI
[ Mon, Apr 08th 2019
] - WOPRAI
[ Mon, Apr 08th 2019
] - WOPRAI
[ Mon, Apr 08th 2019
] - WOPRAI
[ Mon, Apr 08th 2019
] - WOPRAI
[ Mon, Apr 08th 2019
] - WOPRAI
[ Mon, Apr 08th 2019
] - WOPRAI
[ Mon, Apr 08th 2019
] - WOPRAI
[ Mon, Apr 08th 2019
] - WOPRAI
[ Mon, Apr 08th 2019
] - WOPRAI
Fri, April 5, 2019
[ Fri, Apr 05th 2019
] - WOPRAI
[ Fri, Apr 05th 2019
] - WOPRAI
[ Fri, Apr 05th 2019
] - WOPRAI
[ Fri, Apr 05th 2019
] - WOPRAI
Michelle Gilson Maintained (ASND) at Strong Buy with Increased Target to $133 on, Apr 5th, 2019
Michelle Gilson of Canaccord Genuity, Maintained "Ascendis Pharma A/S" (ASND) at Strong Buy with Increased Target from $132 to $133 on, Apr 5th, 2019.
Michelle has made no other calls on ASND in the last 4 months.
There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 0 agree with Michelle's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Michelle
- Alethia Young of "Credit Suisse" Maintained at Buy with Decreased Target to $139 on, Friday, March 29th, 2019
- Joseph Schwartz of "Leerink Swann" Upgraded from Hold to Buy and Increased Target to $90 on, Thursday, January 24th, 2019
Similar Stocks and Investing Articles
[ Fri, Mar 29th 2019
] - WOPRAI
[ Thu, May 31st 2018
] - WOPRAI
[ Tue, May 29th 2018
] - WOPRAI
[ Fri, May 25th 2018
] - WOPRAI
[ Wed, May 16th 2018
] - WOPRAI
[ Mon, Apr 30th 2018
] - WOPRAI
[ Fri, Mar 02nd 2018
] - WOPRAI
[ Thu, May 11th 2017
] - WOPRAI
[ Fri, Apr 29th 2016
] - WOPRAI
[ Thu, Apr 07th 2016
] - WOPRAI